Brio Capital Master Fund Ltd. 13D and 13G filings for Sigyn Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:38 pm Purchase | 2024-11-19 | 13G | Sigyn Therapeutics, Inc. SIGY | Brio Capital Master Fund Ltd. | 158,932 9.990% | 36,828 (+30.16%) | Filing |
| 2024-02-08 12:48 pm Purchase | 2024-01-09 | 13G | Sigyn Therapeutics, Inc. SIGY | Brio Capital Master Fund Ltd. | 122,104 9.990% | 122,104 (New Position) | Filing |